Rehabilitation Interventions Aid Post-COVID-19 Condition
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
WEDNESDAY, Sept. 20, 2023 -- Standardized rehabilitation interventions are associated with improvements in functional exercise capacity in patients with post-COVID-19 condition (PCC), according to a review published online Sept. 19 in JAMA Network Open.
Dimitra V. Pouliopoulou, from Western University in London, Ontario, Canada, and colleagues conducted a systematic literature review to assess whether respiratory training and exercise-based rehabilitation interventions are associated with improved functional exercise capacity and improved quality of life in adults with PCC. The analysis included 14 randomized controlled studies (1,244 patients)
The researchers found that rehabilitation interventions were associated with improvements in functional exercise capacity with moderate-certainty evidence among seven of the trials (standardized mean difference, −0.56). Compared with the current standard of care, these improvements had a 99 percent posterior probability of superiority, although there was significant uncertainty and imprecision regarding the probability of experiencing exercise-induced adverse events (odds ratio, 1.68; 95 percent credible interval, 0.32 to 9.94).
"The findings of this systematic review and meta-analysis suggest that rehabilitation interventions are associated with improvements in functional exercise capacity, dyspnea, and quality of life, with a high probability of improvement compared with the current standard care," the authors write.
One author disclosed ties the pharmaceutical and health care technology industries.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Further Support and Information on COVID-19
Read this next
Higher COVID-19 Vaccination Rates Tied to Decrease in Childhood Asthma Symptoms
WEDNESDAY, July 3, 2024 -- Higher COVID-19 vaccination rates are associated with a lower prevalence of parent-reported childhood asthma symptoms, according to a research letter...
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.